Aclarion, Inc. (ACONW) stock
ACONWNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACON
$0.02+0.00 (0.00%)
Close on Oct 30, 2026Market cap $5.62MP/E –Yield –
Aclarion free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Aclarion's free cash flow for the twelve months ending Dec 31, 2025 was -$7.19M. For fiscal 2025 it was -$7.19M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.19M | – |
| FY2024 | Dec 31, 2024 | -$5.28M | – |
| FY2023 | Dec 31, 2023 | -$3.65M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -$1.64M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.17M | – |
| Q4 FY2024 | Dec 31, 2024 | -$927.98K | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.06M | – |